Autoantigen la promotes efficient RNAi, antiviral response, and transposon silencing by facilitating multiple-turnover RISC catalysis

Ying Liu, Huiling Tan, Hui Tian, Chunyang Liang, She Chen, Qinghua Liu

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The effector of RNA interference (RNAi) is the RNA-induced silencing complex (RISC). C3PO promotes the activation of RISC by degrading the Argonaute2 (Ago2)-nicked passenger strand of duplex siRNA. Active RISC is a multiple-turnover enzyme that uses the guide strand of siRNA to direct the Ago2-mediated sequence-specific cleavage of complementary mRNA. How this effector step of RNAi is regulated is currently unknown. Here, we used the human Ago2 minimal RISC system to purify Sjögren's syndrome antigen B (SSB)/autoantigen La as an activator of the RISC-mediated mRNA cleavage activity. Our reconstitution studies showed that La could promote multiple-turnover RISC catalysis by facilitating the release of cleaved mRNA from RISC. Moreover, we demonstrated that La was required for efficient RNAi, antiviral defense, and transposon silencing in vivo. Taken together, the findings of C3PO and La reveal a general concept that regulatory factors are required to remove Ago2-cleaved products to assemble or restore active RISC.

Original languageEnglish (US)
Pages (from-to)502-508
Number of pages7
JournalMolecular Cell
Volume44
Issue number3
DOIs
StatePublished - Nov 4 2011

Fingerprint

RNA-Induced Silencing Complex
Autoantigens
RNA Interference
Catalysis
Antiviral Agents
Messenger RNA
Small Interfering RNA
Antigens

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Autoantigen la promotes efficient RNAi, antiviral response, and transposon silencing by facilitating multiple-turnover RISC catalysis. / Liu, Ying; Tan, Huiling; Tian, Hui; Liang, Chunyang; Chen, She; Liu, Qinghua.

In: Molecular Cell, Vol. 44, No. 3, 04.11.2011, p. 502-508.

Research output: Contribution to journalArticle

Liu, Ying ; Tan, Huiling ; Tian, Hui ; Liang, Chunyang ; Chen, She ; Liu, Qinghua. / Autoantigen la promotes efficient RNAi, antiviral response, and transposon silencing by facilitating multiple-turnover RISC catalysis. In: Molecular Cell. 2011 ; Vol. 44, No. 3. pp. 502-508.
@article{d4d8b607d4174e2f95b870d60cf68cde,
title = "Autoantigen la promotes efficient RNAi, antiviral response, and transposon silencing by facilitating multiple-turnover RISC catalysis",
abstract = "The effector of RNA interference (RNAi) is the RNA-induced silencing complex (RISC). C3PO promotes the activation of RISC by degrading the Argonaute2 (Ago2)-nicked passenger strand of duplex siRNA. Active RISC is a multiple-turnover enzyme that uses the guide strand of siRNA to direct the Ago2-mediated sequence-specific cleavage of complementary mRNA. How this effector step of RNAi is regulated is currently unknown. Here, we used the human Ago2 minimal RISC system to purify Sj{\"o}gren's syndrome antigen B (SSB)/autoantigen La as an activator of the RISC-mediated mRNA cleavage activity. Our reconstitution studies showed that La could promote multiple-turnover RISC catalysis by facilitating the release of cleaved mRNA from RISC. Moreover, we demonstrated that La was required for efficient RNAi, antiviral defense, and transposon silencing in vivo. Taken together, the findings of C3PO and La reveal a general concept that regulatory factors are required to remove Ago2-cleaved products to assemble or restore active RISC.",
author = "Ying Liu and Huiling Tan and Hui Tian and Chunyang Liang and She Chen and Qinghua Liu",
year = "2011",
month = "11",
day = "4",
doi = "10.1016/j.molcel.2011.09.011",
language = "English (US)",
volume = "44",
pages = "502--508",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Autoantigen la promotes efficient RNAi, antiviral response, and transposon silencing by facilitating multiple-turnover RISC catalysis

AU - Liu, Ying

AU - Tan, Huiling

AU - Tian, Hui

AU - Liang, Chunyang

AU - Chen, She

AU - Liu, Qinghua

PY - 2011/11/4

Y1 - 2011/11/4

N2 - The effector of RNA interference (RNAi) is the RNA-induced silencing complex (RISC). C3PO promotes the activation of RISC by degrading the Argonaute2 (Ago2)-nicked passenger strand of duplex siRNA. Active RISC is a multiple-turnover enzyme that uses the guide strand of siRNA to direct the Ago2-mediated sequence-specific cleavage of complementary mRNA. How this effector step of RNAi is regulated is currently unknown. Here, we used the human Ago2 minimal RISC system to purify Sjögren's syndrome antigen B (SSB)/autoantigen La as an activator of the RISC-mediated mRNA cleavage activity. Our reconstitution studies showed that La could promote multiple-turnover RISC catalysis by facilitating the release of cleaved mRNA from RISC. Moreover, we demonstrated that La was required for efficient RNAi, antiviral defense, and transposon silencing in vivo. Taken together, the findings of C3PO and La reveal a general concept that regulatory factors are required to remove Ago2-cleaved products to assemble or restore active RISC.

AB - The effector of RNA interference (RNAi) is the RNA-induced silencing complex (RISC). C3PO promotes the activation of RISC by degrading the Argonaute2 (Ago2)-nicked passenger strand of duplex siRNA. Active RISC is a multiple-turnover enzyme that uses the guide strand of siRNA to direct the Ago2-mediated sequence-specific cleavage of complementary mRNA. How this effector step of RNAi is regulated is currently unknown. Here, we used the human Ago2 minimal RISC system to purify Sjögren's syndrome antigen B (SSB)/autoantigen La as an activator of the RISC-mediated mRNA cleavage activity. Our reconstitution studies showed that La could promote multiple-turnover RISC catalysis by facilitating the release of cleaved mRNA from RISC. Moreover, we demonstrated that La was required for efficient RNAi, antiviral defense, and transposon silencing in vivo. Taken together, the findings of C3PO and La reveal a general concept that regulatory factors are required to remove Ago2-cleaved products to assemble or restore active RISC.

UR - http://www.scopus.com/inward/record.url?scp=80555135907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80555135907&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2011.09.011

DO - 10.1016/j.molcel.2011.09.011

M3 - Article

VL - 44

SP - 502

EP - 508

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 3

ER -